Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass Grafting: Comparative Effectiveness Analysis

Ali Hage1, Vincenzo Giambruno1, Philip Jones2

  • 1Division of Cardiac Surgery Department of Surgery Western University London Health Sciences Centre London Ontario Canada.

Insights

Hybrid coronary revascularization (HCR) offers a shorter recovery for selected patients with multivessel coronary artery disease compared to off-pump coronary artery bypass grafting (CABG). Both HCR and CABG demonstrate excellent long-term outcomes, with HCR showing improved survival trends and freedom from angina.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Medical Technology

Background:

  • Hybrid coronary revascularization (HCR) combines coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) for multivessel coronary artery disease.
  • Off-pump CABG is a conventional surgical approach for treating similar conditions.

Purpose of the Study:

  • To compare the long-term outcomes of HCR versus conventional off-pump CABG.
  • To evaluate the efficacy and safety of HCR in selected patients.

Main Methods:

  • A propensity score analysis using inverse-probability weighting was performed.
  • Compared outcomes between 216 off-pump CABG patients and 147 HCR patients (robotic-assisted minimally invasive direct CABG + PCI).
  • Follow-up extended to a median of 81 months for CABG and 96 months for HCR.

Main Results:

  • HCR demonstrated a shorter hospital length of stay and lower rates of prolonged mechanical ventilation.
  • In-hospital reintervention rates were higher in the HCR group (3.4% vs. 0%).
  • HCR showed a trend toward improved survival (96% vs. 85%) and significantly better freedom from angina (90% vs. 73%).

Conclusions:

  • HCR provides a shorter postoperative recovery in selected patients.
  • HCR demonstrates comparable excellent short- and long-term outcomes to off-pump CABG.
  • HCR may offer advantages in survival trends and symptom relief for specific patient groups.